TNSN01003A1 - Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes. - Google Patents

Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.

Info

Publication number
TNSN01003A1
TNSN01003A1 TNTNSN01003A TNSN01003A TNSN01003A1 TN SN01003 A1 TNSN01003 A1 TN SN01003A1 TN TNSN01003 A TNTNSN01003 A TN TNSN01003A TN SN01003 A TNSN01003 A TN SN01003A TN SN01003 A1 TNSN01003 A1 TN SN01003A1
Authority
TN
Tunisia
Prior art keywords
hydrofluoroalkan
propellers
aerosols
delivery
dose counting
Prior art date
Application number
TNTNSN01003A
Other languages
English (en)
Inventor
Gaetano Brambilla
Isabella Panza
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11443627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN01003(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of TNSN01003A1 publication Critical patent/TNSN01003A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nozzles (AREA)
  • Cosmetics (AREA)

Abstract

UN APPAREIL D'ADMINISTRATION D'AEROSOLS A COMPTAGE DE DOSE COMPORTANT UN INGREDIENT ACTIF DANS UNE SOLUTION CONTINUE DANS UN PROPULSEUR HYDROFLUORALCANE, UN COSOLVANT ET OPTIONNELLEMENT UN COMPOSANT DE FAIBLE VOLATILITE.
TNTNSN01003A 2000-01-07 2001-01-05 Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes. TNSN01003A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000010A IT1317720B1 (it) 2000-01-07 2000-01-07 Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.

Publications (1)

Publication Number Publication Date
TNSN01003A1 true TNSN01003A1 (fr) 2003-04-03

Family

ID=11443627

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01003A TNSN01003A1 (fr) 2000-01-07 2001-01-05 Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.

Country Status (23)

Country Link
US (1) US20050034720A1 (fr)
EP (1) EP1244487B1 (fr)
AT (1) ATE342081T1 (fr)
AU (1) AU2512801A (fr)
BR (1) BR0107730B1 (fr)
CA (1) CA2396273C (fr)
CZ (1) CZ303394B6 (fr)
DE (1) DE60123746T2 (fr)
DK (1) DK1244487T3 (fr)
DZ (1) DZ3243A1 (fr)
EG (1) EG22790A (fr)
ES (1) ES2273800T3 (fr)
HU (1) HU229516B1 (fr)
IT (1) IT1317720B1 (fr)
JO (1) JO2506B1 (fr)
MA (1) MA26392A1 (fr)
PL (1) PL198683B1 (fr)
PT (1) PT1244487E (fr)
SA (1) SA01210645B1 (fr)
SI (1) SI1244487T1 (fr)
SK (1) SK286139B6 (fr)
TN (1) TNSN01003A1 (fr)
WO (1) WO2001049350A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
WO2003026559A2 (fr) * 2001-09-28 2003-04-03 Kurve Technology, Inc Nebuliseur nasal
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
WO2003099359A1 (fr) 2002-05-09 2003-12-04 Kurve Technology, Inc. Chambre de dispersion de particules pour nebuliseur nasal
US20070095342A1 (en) * 2005-10-18 2007-05-03 Bijan Olfati Accessorized inhaler
EP2106268B1 (fr) 2006-08-30 2018-12-12 Kurve Technology, Inc. Dispositif de génération et de délivrance d'aérosol
BRPI0603695A (pt) * 2006-09-13 2008-04-29 Cesar Eduardo Marques Da Silva aerocámara para aplicação de medicamentos aerossol com válvula geométrica
CA2709071C (fr) 2007-12-14 2016-11-15 Labogroup S.A.S. Administration de produits alimentaires sous forme d'aerosols
EP2080507A1 (fr) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulations pharmaceutiques comprenant un médicament anticholinérgique
CN102548537B (zh) 2009-10-02 2014-06-25 奇斯药制品公司 福莫特罗和二丙酸倍氯米松的药用气雾制剂
US20120272951A1 (en) * 2009-12-16 2012-11-01 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
EA021604B1 (ru) 2009-12-23 2015-07-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Аэрозольная композиция для лечения астмы и copd
BR112012015335B1 (pt) 2009-12-23 2021-05-18 Chiesi Farmaceutici S.P.A. formulação de aerossol para doença pulmonar obstrutiva crõnica
WO2011076843A2 (fr) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Polythérapie pour bronchopneumopathie chronique obstructive (copd)
WO2011076841A2 (fr) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Polythérapie destinée à la bronchopneumopathie chronique obstructive
WO2013114373A1 (fr) 2012-02-01 2013-08-08 Protalix Ltd. Formulations liquides inhalables d'adnase i
PL3089735T3 (pl) 2013-12-30 2018-12-31 Chiesi Farmaceutici S.P.A. Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IT1244441B (it) * 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
AU663093B2 (en) * 1991-05-21 1995-09-28 Abbott Laboratories Aerosol inhalation device
EP0601036B1 (fr) * 1991-08-29 1999-04-28 Broncho-Air Medizintechnik AG Appareil medical pour inhaler des doses d'aerosols
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
PL177078B1 (pl) * 1992-12-09 1999-09-30 Boehringer Ingelheim Pharma Preparaty roztworów aerozolowych
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
GB9311892D0 (en) * 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
JPH09506896A (ja) * 1993-12-20 1997-07-08 ミネソタ マイニング アンド マニュファクチャリング カンパニー フルニゾリド・エアロゾル配合品
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
DE69636757T2 (de) * 1995-04-14 2007-10-11 Smithkline Beecham Corp. Dosierinhalator für Fluticasonepropionat
PT820279E (pt) * 1995-04-14 2002-11-29 Smithkline Beecham Corp Inalador de doses calibradas para albuterol
EP1908488A3 (fr) * 1995-04-14 2008-04-16 SmithKline Beecham Corporation Inhalateur de dose mesurée pour le salmétérol
SK139197A3 (en) * 1995-04-14 1998-04-08 Glaxo Wellcome Inc Metered dose inhaler for beclomethasone dipropionate
WO1998003533A1 (fr) 1996-07-24 1998-01-29 Oligos Etc. And Oligos Therapeutics, Inc. Oligonucleotides anti-sens utilises comme agents antibacteriens
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
PT1014943E (pt) * 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois
US6193954B1 (en) * 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) * 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en) * 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP2000112547A (ja) * 1998-10-05 2000-04-21 Mitsubishi Electric Corp 基板電圧発生回路および半導体集積回路装置
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
ES2192866T3 (es) * 1998-11-13 2003-10-16 Jago Res Ag Polvo seco para inhalacion.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
FR2798290B1 (fr) * 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DK1273292T3 (da) * 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
US6616193B2 (en) * 2001-10-03 2003-09-09 Kool, L.L.C. Ventilating system connector assembly and method of use
EP1415647A1 (fr) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. Beta-2-agonistes à activité de longue durée dans une formulation ultrafine
ES2745064T3 (es) * 2002-03-01 2020-02-27 Chiesi Farm Spa Formulación superfina de formoterol
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique

Also Published As

Publication number Publication date
SI1244487T1 (sl) 2007-04-30
ITMI20000010A0 (it) 2000-01-07
EG22790A (en) 2003-08-31
PL198683B1 (pl) 2008-07-31
HU229516B1 (en) 2014-01-28
ATE342081T1 (de) 2006-11-15
SK286139B6 (sk) 2008-04-07
AU2512801A (en) 2001-07-16
PT1244487E (pt) 2007-01-31
CZ20022331A3 (cs) 2002-11-13
CA2396273A1 (fr) 2001-07-12
SA01210645B1 (ar) 2007-07-31
DE60123746T2 (de) 2007-10-11
DK1244487T3 (da) 2007-02-19
BR0107730B1 (pt) 2009-05-05
HUP0300405A2 (hu) 2003-06-28
EP1244487A1 (fr) 2002-10-02
PL356849A1 (en) 2004-07-12
US20050034720A1 (en) 2005-02-17
IT1317720B1 (it) 2003-07-15
MA26392A1 (fr) 2004-12-01
DE60123746D1 (de) 2006-11-23
CA2396273C (fr) 2009-11-17
SK9482002A3 (en) 2002-10-08
JO2506B1 (en) 2009-10-05
ES2273800T3 (es) 2007-05-16
WO2001049350A1 (fr) 2001-07-12
HUP0300405A3 (en) 2003-07-28
EP1244487B1 (fr) 2006-10-11
ITMI20000010A1 (it) 2001-07-07
CZ303394B6 (cs) 2012-08-29
BR0107730A (pt) 2003-02-25
DZ3243A1 (fr) 2001-07-12

Similar Documents

Publication Publication Date Title
TNSN01003A1 (fr) Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
DK0799024T3 (da) Farmaceutisk aerosol indeholdende mindst en sukker
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
FI941771A (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
PT918507E (pt) Formulacoes em aerossol
SE0102276D0 (sv) Device and method for the administration of a medicament
EA199900991A1 (ru) Медицинские аэрозольные препараты
ATE292453T1 (de) Antivirale arznei
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
NZ508371A (en) Therapeutic anti-cold agent containing isomalt as an active ingredient
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
PL348202A1 (en) Pharmaceutically active composition and dispensing device
UA90346C2 (ru) Фармацевтическая рецептура для перорального приема и способ введения пациенту